In this regard, we recently observed that BTC cell lines with high basal p-AKT expression respond preferentially to everolimus in vitro.28 Similarly, renal and gastric cancers harbouring higher basal activation of the PI3K/AKT/mTOR pathway have also been reported to show improved response to everolimus.29,30. This evidence concerns the gene PIK3CA and gastric cancer.